0 Comments
0 Shares
138 Views
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Complement C3 ELISA Kits Market – Immunology Research Drives Diagnostic DemandThe complement C3 ELISA kits market is expanding as autoimmune disease research, inflammation studies, precision medicine, and clinical diagnostics increase worldwide. The market was valued at USD 400 million in 2024 and is projected to reach USD 800 million by 2035, growing at a CAGR of 6.3%. 1034 Complement C3 is an important protein within the complement system, a component of the immune...0 Comments 0 Shares 72 Views
-
Immunology Market – Advancements in Biopharmaceuticals Driving ExpansionImmunology Market – Advancements in Biopharmaceuticals Driving Expansion Market Overview and Growth Snapshot The Immunology Biopharmaceutical Segment is a major contributor to market growth, valued at approximately USD 49.88 billion in 2025 and expected to reach USD 86.81 billion by 2033, growing at a CAGR of 7%. The increasing use of biologic drugs has significantly improved...0 Comments 0 Shares 244 Views
-
Immunology Market Growth Factors and Industry Development OverviewThe immunology market is gradually transforming as it gears up for significant advancements and shifts in treatment methodologies. The market is projected to reach a size of approximately 220.18 USD by 2035, reflecting a robust compound annual growth rate (CAGR) of 6.58%. This anticipated growth can be attributed to a variety of factors, including the rising prevalence of autoimmune diseases...0 Comments 0 Shares 109 Views
-
Immunology Market: Key Growth Drivers and Future ProspectsThe Immunology Market is gaining strategic importance as pharmaceutical and biotechnology companies expand their focus on immune-mediated diseases and targeted treatment development. Greater understanding of immune pathways has created opportunities to address conditions that previously relied heavily on broad immunosuppressive approaches. Rising recognition of chronic inflammatory disorders,...0 Comments 0 Shares 55 Views
-
Next Generation Immunology Drug Market Insights Across Modern Treatment ApproachesThe Next Generation Immunology Drug Market is set for a transformative journey, with projections indicating it could reach USD 83.84 billion by 2035, reflecting a robust CAGR of 6.55%. With the market starting at USD 41.71 billion in 2024 and moving to USD 44.44 billion in 2025, the growth trajectory underscores the escalating demand for innovative immunotherapies. The shift towards...0 Comments 0 Shares 112 Views
-
North America Humanized Mice Model Market Trends in Immunology Research 2034The North America Humanized Mice Model Market is benefiting from ongoing research into immunotherapies, infectious diseases, and immune-mediated disorders. Pharmaceutical companies and academic institutions are using humanized mice to investigate disease progression and evaluate experimental treatments. The Humanized Mice Model Market was valued at US$ 272.06 million in 2025 and is projected...0 Comments 0 Shares 80 Views
-
Tremfya Market Outlook Amid Advances in Immunology TreatmentsTremfya (guselkumab), developed by Johnson & Johnson, is a monoclonal antibody that selectively targets the p19 subunit of interleukin-23. Polaris Market Research values the Tremfya market at USD 4.2 billion in 2025, with a projected CAGR of 7.40% from 2026 to 2034 and USD 7.99 billion by 2034. This article focuses on how label expansion, access support, and competition are shaping the...0 Comments 0 Shares 215 Views
Bangla